PubMed · 6973712
Polyclonal B-cell activity in myasthenia gravis.
Abstract
Using a protein A-reverse hemolytic plaque assay, we found that some patients with myasthenia gravis have increased numbers of circulating immunoglobulin secreting cells (IgSC). This pattern was not related to drug therapy, age, sex, duration of symptoms, thymectomy, or serum levels of AChR antibody, although elevated IgSC values tended to occur in patients with active symptoms. The responses of peripheral blood mononuclear cells to pokeweed mitogen were normal. These data suggest increased in vivo polyclonal B-cell activation in some myasthenic patients, although in vitro polyclonal B-cell activation is normal.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
A I Levinson, A Dziarski, R P Lisak, B Zweiman, A R Moskovitz, T Brenner, O Abramsky. 1981. Polyclonal B-cell activity in myasthenia gravis.. https://doi.org/10.1212/wnl.31.9.1198
Cite the original work for its findings. Save a collection to share your selection of sources.